Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Interventional × pamrevlumab × Clear all

Phase

Phase NA 1 Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Cancer Non-resectable 1

Interventions

Cisplatin 724 Carboplatin 606 Paclitaxel 576 Cyclophosphamide 517 Radiotherapy 510 Docetaxel 473 Fluorouracil 449 Gemcitabine 433 Doxorubicin 384 Capecitabine 357 Dexamethasone 324 Oxaliplatin 284 Leucovorin 281 pembrolizumab 280 Etoposide 272 Vincristine 271 Bevacizumab 271 Rituximab 245 Prednisone 223 Pemetrexed 217 Cytarabine 205 Drug Therapy 193 Trastuzumab 174 Methotrexate 171 Irinotecan 169 Lenalidomide 136 Nivolumab 135 Filgrastim 135 Epirubicin 129 Tamoxifen 127

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03941093 2024-11-05

LAPIS

Kyntra Bio

Phase 3 Completed

284 enrolled 14 charts

Gastrointestinal

Pancreatic Cancer Non-resectable

Data powered by HemOnc (CC BY 4.0) Colophon ⚡